Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
PVH
PVH
$4.01B
| $1.4M | ﹤0.01% |
19,841
-111,044
| -85% | -$6.62M |
|
2477
Genesco
GCO
$435M
| $1.4M | ﹤0.01% |
30,410
-17,663
| -37% | -$801K |
|
2478
PUT
EOG Resources
EOG
$71B
| $1.4M | ﹤0.01% |
+10,800
| New | +$1.44M |
|
2479
First Financial Bancorp
FFBC
$3.63B
| $1.39M | ﹤0.01% |
57,560
+27,282
| +90% | +$671K |
|
2480
Alamo Group
ALG
$2.05B
| $1.39M | ﹤0.01% |
9,843
+2,121
| +27% | +$307K |
|
2481
Calix
CALX
$2.38B
| $1.39M | ﹤0.01% |
20,362
+12,425
| +157% | +$835K |
|
|
VSAC
2482
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
| $1.39M | ﹤0.01% |
135,204
| – | – |
|
2483
ONE Gas
OGS
$5.02B
| $1.39M | ﹤0.01% |
18,336
-3,930
| -18% | -$303K |
|
2484
Brilliant Earth
BRLT
$19M
| $1.39M | ﹤0.01% |
321,924
-50,067
| -13% | -$300K |
|
2485
United Natural Foods
UNFI
$2.97B
| $1.39M | ﹤0.01% |
35,832
+5,970
| +20% | +$247K |
|
|
DCH
2486
Dauch Corp
DCH
$1.4B
| $1.39M | ﹤0.01% |
177,190
+86,392
| +95% | +$774K |
|
2487
Starwood Property Trust
STWD
$5.9B
| $1.39M | ﹤0.01% |
75,591
+15,180
| +25% | +$302K |
|
|
GOLD
2488
Gold.com Inc
GOLD
$1.27B
| $1.38M | ﹤0.01% |
39,806
+10,328
| +35% | +$327K |
|
|
SUM
2489
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $1.38M | ﹤0.01% |
48,625
-2,557
| -5% | -$70.5K |
|
|
NBP
2490
NovaBridge Biosciences American Depositary Shares
NBP
$198M
| $1.38M | ﹤0.01% |
+329,300
| New | +$1.25M |
|
2491
Tecnoglass Holdings Inc.
TGLS
$2.03B
| $1.37M | ﹤0.01% |
44,654
-19,011
| -30% | -$491K |
|
2492
Gerdau
GGB
$9.89B
| $1.37M | ﹤0.01% |
312,146
| – | – |
|
2493
Dana Inc
DAN
$3.19B
| $1.37M | ﹤0.01% |
90,706
+4,821
| +6% | +$74.8K |
|
2494
Clean Harbors
CLH
$16.4B
| $1.37M | ﹤0.01% |
12,011
+4,586
| +62% | +$536K |
|
2495
Genco Shipping & Trading
GNK
$1.1B
| $1.37M | ﹤0.01% |
89,011
+87,456
| +5,624% | +$1.27M |
|
|
TIPD
2496
DELISTED
Direxion Daily TIPS Bear 2X Shares
TIPD
| $1.37M | ﹤0.01% |
50,000
| – | – |
|
2497
CGI
GIB
$15B
| $1.36M | ﹤0.01% |
15,839
-17,958
| -53% | -$1.48M |
|
2498
SkinHealth Systems
SKIN
$88.9M
| $1.36M | ﹤0.01% |
149,669
-206,158
| -58% | -$2.23M |
|
2499
MYR Group
MYRG
$5.2B
| $1.36M | ﹤0.01% |
14,780
+2,749
| +23% | +$249K |
|
|
MRSN
2500
DELISTED
Mersana Therapeutics
MRSN
| $1.36M | ﹤0.01% |
9,284
+3,855
| +71% | +$652K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.